Literature DB >> 23148634

Genetic polymorphisms and novel allelic variants of CYP2C19 in the Chinese Han population.

Li-Ming Hu1, Da-Peng Dai, Guo-Xin Hu, Jie-Fu Yang, Ren-Ai Xu, Li-Ping Yang, Jian-Chang Qian, Ren-Shan Ge, Jian-Ping Cai.   

Abstract

AIM: This study aims to systematically investigate the genetic polymorphisms of the CYP2C19 gene and provide accurate data of the allele distribution pattern in the Chinese Han population. MATERIALS &
METHODS: We amplified all nine exons of the CYP2C19 gene in 2127 unrelated healthy Chinese Han subjects from two geographical locations (Zhejiang province, n = 1127; Hebei province, n = 1000), using direct sequencing.
RESULTS: In total, six previously reported alleles were found in our study, in which two alleles CYP2C19*6 and CYP2C19*18 were reported for the first time in Chinese Han subjects. In addition, 35 novel variants were detected in the present work, which included 11 new named alleles, 12 nonsynonymous mutations and one insert variant.
CONCLUSION: This study provides important data on the pattern of CYP2C19 polymorphisms in Chinese Han subjects, using the largest group of individuals. Furthermore, the study also detects the largest number of novel alleles in one population. These findings are of potential benefit to the development of personalized medicine for the Chinese Han population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23148634     DOI: 10.2217/pgs.12.141

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  9 in total

Review 1.  Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations.

Authors:  I Fricke-Galindo; C Céspedes-Garro; F Rodrigues-Soares; M E G Naranjo; Á Delgado; F de Andrés; M López-López; E Peñas-Lledó; A LLerena
Journal:  Pharmacogenomics J       Date:  2015-10-27       Impact factor: 3.550

2.  Genetic polymorphisms and phenotypic analysis of drug-metabolizing enzyme CYP2C19 in a Li Chinese population.

Authors:  Yipeng Ding; Dongchuan Xu; Xiyang Zhang; Hua Yang; Tingting Geng; Ping He; Jinjian Yao; Shengyang Yi; Heping Xu; Duoyi Wu; Xiang Wang; Tianbo Jin
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

3.  Effects of Simvastatin on the Metabolism of Vonoprazan in Rats Both in vitro and in vivo.

Authors:  Yun Hong; Da-Peng Dai; Jian-Ping Cai; Shuang-Hu Wang; Yi-Ran Wang; Fang-Ling Zhao; Shan Zhou; Quan Zhou; Pei-Wu Geng; Yun-Fang Zhou; Xue Xu; Ji-Hua Shi; Qing-Feng Luo
Journal:  Drug Des Devel Ther       Date:  2022-06-09       Impact factor: 4.319

4.  Effects of CYP2C19 variants on the metabolism of tapentadol in vitro.

Authors:  Ren-Ai Xu; Ping Fang; Zhize Ye; Mingming Han; Jian-Ping Cai; Guo-Xin Hu
Journal:  Iran J Basic Med Sci       Date:  2022-05       Impact factor: 2.532

5.  The effects of cytochrome P450 2C19 polymorphism on the metabolism of voriconazole in vitro.

Authors:  Ren-Ai Xu; Er-Min Gu; Teng-Hui Liu; Qiu-Geng Ou-Yang; Guo-Xin Hu; Jian-Ping Cai
Journal:  Infect Drug Resist       Date:  2018-11-01       Impact factor: 4.003

6.  Genetic Epidemiology of Medication Safety and Efficacy Related Variants in the Central Han Chinese Population With Whole Genome Sequencing.

Authors:  Junbo Tian; Jing Zhang; Zengguang Yang; Shuaisheng Feng; Shujuan Li; Shiqi Ren; Jianxiang Shi; Xinyue Hou; Xia Xue; Bei Yang; Hongen Xu; Jiancheng Guo
Journal:  Front Pharmacol       Date:  2022-02-23       Impact factor: 5.810

7.  Impact of extracorporeal membrane oxygenation on voriconazole plasma concentrations: A retrospective study.

Authors:  Qinghua Ye; Xin Yu; Wenqian Chen; Min Li; Sichao Gu; Linna Huang; Qingyuan Zhan; Chen Wang
Journal:  Front Pharmacol       Date:  2022-08-17       Impact factor: 5.988

8.  The Effects of CYP2C19 genotype on the susceptibility for nephrosis in cardio-cerebral vascular disease treated by anticoagulation.

Authors:  Kai Chang; Zhongyong Jiang; Chenxia Liu; Junlong Ren; Ting Wang; Jie Xiong
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

9.  The correlation between recurrent risk and CYP2C19 gene polymorphisms in patients with ischemic stroke treated with clopidogrel for prevention.

Authors:  Guohua Liu; Sufang Yang; Siqia Chen
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.